Meenhard Herlyn
#122,188
Most Influential Person Now
Meenhard Herlyn's AcademicInfluence.com Rankings
Meenhard Herlynphilosophy Degrees
Philosophy
#5573
World Rank
#8412
Historical Rank
Logic
#2830
World Rank
#3889
Historical Rank

Download Badge
Philosophy
Meenhard Herlyn's Degrees
- Doctorate Medicine University of Hamburg
Why Is Meenhard Herlyn Influential?
(Suggest an Edit or Addition)Meenhard Herlyn's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Colorectal carcinoma antigens detected by hybridoma antibodies (1979) (1355)
- Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. (1990) (768)
- Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. (1979) (668)
- Specific antigen in serum of patients with colon carcinoma. (1981) (594)
- N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. (2001) (493)
- Gastrointestinal cancer-associated antigen in immunoperoxidase assay. (1982) (440)
- Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation. (2003) (437)
- Suppression of BRAF(V599E) in human melanoma abrogates transformation. (2003) (417)
- E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. (2000) (350)
- Study of antibodies against human melanoma produced by somatic cell hybrids. (1978) (345)
- Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma. (1983) (317)
- Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies. (1984) (301)
- Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine. (1994) (298)
- Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor. (1989) (284)
- Characteristics of cultured human melanocytes isolated from different stages of tumor progression. (1985) (283)
- Cyclin D1 is a candidate oncogene in cutaneous melanoma. (2002) (281)
- Biology of tumor progression in human melanocytes. (1987) (258)
- Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody. (1980) (255)
- Shifts in cadherin profiles between human normal melanocytes and melanomas. (1996) (254)
- Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. (1993) (242)
- Regulation of extracellular matrix proteins and integrin cell substratum adhesion receptors on epithelium during cutaneous human wound healing in vivo. (1993) (232)
- Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma. (1998) (229)
- Human melanoma progression in skin reconstructs : biological significance of bFGF. (2000) (228)
- Cytogenetics of human malignant melanoma and premalignant lesions. (1984) (225)
- Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. (1991) (214)
- Expression of the receptor for epidermal growth factor correlates with increased dosage of chromosome 7 in malignant melanoma (1985) (209)
- Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development (2001) (205)
- CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations (2009) (204)
- Melanoma development and progression: a conspiracy between tumor and host. (2002) (203)
- Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. (1999) (203)
- Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2. (2013) (202)
- Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma. (1999) (191)
- Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes. (1991) (190)
- Chromatin binding of epidermal growth factor, nerve growth factor, and platelet-derived growth factor in cells bearing the appropriate surface receptors. (1986) (188)
- Function and regulation of melanoma–stromal fibroblast interactions: when seeds meet soil (2003) (187)
- Karyotypic evolution in human malignant melanoma. (1986) (184)
- Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression. (2000) (183)
- Melanoma cells and normal melanocytes share antigens recognized by HLA- A2-restricted cytotoxic T cell clones from melanoma patients (1993) (181)
- Absence of BRAF mutations in UV-protected mucosal melanomas (2004) (180)
- Tumor growth modulation by a monoclonal antibody to the epidermal growth factor receptor: immunologically mediated and effector cell-independent effects. (1987) (172)
- The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. (1995) (167)
- Differential response of primary and metastatic melanomas to neutrophils attracted by IL‐8 (2003) (166)
- Binding of an antagonistic monoclonal antibody to an intact and fragmented EGF-receptor polypeptide. (1987) (163)
- Molecular events in melanoma development and progression. (1998) (158)
- Mouse monoclonal antibodies against human cancer cell lines with specificities for blood group and related antigens. Characterization by antibody binding to glycosphingolipids in a chromatogram binding assay. (1983) (155)
- Primary melanoma cells of the vertical growth phase: similarities to metastatic cells. (1985) (150)
- Human melanoma cell lines of primary and metastatic origin express the genes encoding the chains of platelet-derived growth factor (PDGF) and produce a PDGF-like growth factor. (1986) (150)
- Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells. (1993) (149)
- Isolation and functional characterization of the A32 melanoma-associated antigen. (1994) (148)
- Monoclonal antibodies in cell‐mediated cytotoxicity against human melanoma and colorectal carcinoma (1979) (148)
- Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells. (1980) (142)
- Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions. (1996) (142)
- Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas. (1989) (137)
- Regulation of Mel-CAM/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes. (1994) (135)
- Adenoviral mediated gene transfer of PDGF‐B enhances wound healing in type I and type II diabetic wounds (2004) (134)
- Monoclonal antibodies directed against the sugar sequence of lacto-N-fucopentaose III are obtained from mice immunized with human tumors. (1982) (130)
- Dynamics of intercellular communication during melanoma development. (2000) (129)
- Radioimmunodetection of human tumor xenografts by monoclonal antibodies. (1983) (127)
- Adenoviral-mediated overexpression of platelet-derived growth factor-B corrects ischemic impaired wound healing. (1999) (126)
- Differentiation of normal skin and melanoma using high resolution hyperspectral imaging (2006) (125)
- Growth and invasion of human melanomas in human skin grafted to immunodeficient mice. (1993) (125)
- Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes (1999) (124)
- Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas. (1999) (124)
- Inhibition of the fibroblast growth factor receptor 1 (FGFR-1) gene in human melanocytes and malignant melanomas leads to inhibition of proliferation and signs indicative of differentiation. (1992) (122)
- Progression-related expression of beta3 integrin in melanomas and nevi. (1999) (122)
- Interleukin-8 Overexpression Is Present in Pyoderma Gangrenosum Ulcers and Leads to Ulcer Formation in Human Skin Xenografts (2000) (121)
- Melanoma antigens: immunological and biological characterization and clinical significance. (1988) (119)
- Proton NMR and fast-atom bombardment mass spectrometry analysis of the melanoma-associated ganglioside 9-O-acetyl-GD3. (1985) (118)
- Undifferentiated keratinocytes control growth, morphology, and antigen expression of normal melanocytes through cell-cell contact. (1993) (116)
- Monoclonal antibody localization of Lewis antigens in fixed tissue. (1984) (114)
- Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression. (1995) (113)
- Growth-regulatory factors for normal, premalignant, and malignant human cells in vitro. (1990) (112)
- Melanoma cell-cell interactions are mediated through heterophilic Mel-CAM/ligand adhesion. (1997) (111)
- Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells. (2000) (111)
- Efficient selection of human tumor growth-inhibiting monoclonal antibodies. (1984) (110)
- Integrin Distribution in Malignant Melanoma : Association of the ß 3 Subunit with Tumor Progression 1 (2006) (108)
- Identification of melanoma-associated antigens using fixed tissue screening of antibodies. (1984) (106)
- The cell-cell adhesion receptor Mel-CAM acts as a tumor suppressor in breast carcinoma. (1997) (105)
- Regulatory factors that determine growth and phenotype of normal human melanocytes. (1988) (105)
- Matrix immobilization enhances the tissue repair activity of growth factor gene therapy vectors. (2001) (105)
- Human/severe combined immunodeficient mouse chimeras. An experimental in vivo model system to study the regulation of human endothelial cell-leukocyte adhesion molecules. (1993) (103)
- Permissive environment in postnatal wounds induced by adenoviral‐mediated overexpression of the anti‐inflammatory cytokine interleukin‐10 prevents scar formation (2008) (103)
- Mutation and expression of the p53 gene in malignant melanoma cell lines (1993) (103)
- Melanoma Chondroitin Sulfate Proteoglycan Regulates Matrix Metalloproteinase-dependent Human Melanoma Invasion into Type I Collagen* (2001) (103)
- T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2- restricted and melanocyte-lineage-specific CTL clone (1993) (101)
- UVB induces atypical melanocytic lesions and melanoma in human skin. (1998) (100)
- A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on paraffin-embedded tissue. (1998) (99)
- Human melanoblasts in culture: expression of BRN2 and synergistic regulation by fibroblast growth factor-2, stem cell factor, and endothelin-3. (2003) (98)
- Lessons from melanocyte development for understanding the biological events in naevus and melanoma formation (2000) (98)
- Cellular and Molecular Biology of Human Melanoma (2002) (96)
- Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and beta-catenin pathways. (2001) (93)
- p73beta, unlike p53, suppresses growth and induces apoptosis of human papillomavirus E6-expressing cancer cells. (1998) (92)
- Malignant melanoma simulants arising in congenital melanocytic nevi do not show experimental evidence for a malignant phenotype. (1990) (92)
- Expression of melanoma-associated antigens in rapidly dividing human melanocytes in culture. (1987) (92)
- Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway (2011) (91)
- Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels (2007) (90)
- MEK inhibition affects STAT3 signaling and invasion in human melanoma cell lines (2014) (89)
- Dynamics of cell interactions and communications during melanoma development. (2002) (88)
- Inhibition of metastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosides. (1989) (88)
- Inhibition of human tumor growth by IgG2A monoclonal antibodies correlates with antibody density on tumor cells. (1985) (88)
- HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes. (1984) (88)
- Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin. (2001) (87)
- Reciprocal regulation of MelCAM and AKT in human melanoma (2003) (86)
- Monoclonal antibody localization of A and B isoantigens in normal and malignant fixed human tissues. (1984) (86)
- The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium. (2008) (86)
- FGF2-Targeted adenovirus encoding platelet-derived growth factor-B enhances de novo tissue formation. (2000) (85)
- Induction of Melanoma Phenotypes in Human Skin by Growth Factors and Ultraviolet B (2004) (85)
- Functional erythropoietin autocrine loop in melanoma. (2005) (84)
- Recombinant gamma-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells. (1985) (83)
- Characterization of chromosome 1 abnormalities in malignant melanomas (2000) (83)
- Biologic and therapeutic significance of MYB expression in human melanoma. (1994) (82)
- Role of growth factors and their receptors in the development and progression of melanoma. (1993) (82)
- Regulatory pathways in tumor growth and invasion. (1991) (80)
- GD2 ganglioside biosynthesis is a distinct biochemical event in human melanoma tumor progression (1986) (79)
- Oncogenic BRAF regulates β-Trcp expression and NF-κB activity in human melanoma cells (2007) (79)
- Bone morphogenetic proteins in melanoma: Angel or devil? (2005) (78)
- CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma. (2015) (78)
- Reactivity of monoclonal anti‐melanoma antibodies with melanoma cells freshly isolated from primary and metastatic melanoma (1979) (76)
- Autocrine and paracrine roles for growth factors in melanoma. (1994) (75)
- Release of monoclonal antibody-defined antigens by human colorectal carcinoma and melanoma cells. (1981) (73)
- Clinical Protocol: Phase I trial to evaluate the safety of H5.020CMV.PDGF‐B for the treatment of a diabetic insensate foot ulcer (2000) (72)
- Production and characterization of monoclonal antibodies against human malignant melanoma. (1983) (72)
- Monoclonal antibody-defined correlations in melanoma between levels of GD2 and GD3 antigens and antibody-mediated cytotoxicity. (1987) (71)
- Melanoma: The Wistar Melanoma (WM) Cell Lines (2002) (70)
- Monoclonal antibody to a highly glycosylated protein reacts in fixed tissue with melanoma and other tumors. (1985) (70)
- Volatile biomarkers from human melanoma cells. (2013) (70)
- Presence of tumor-associated antigens in epidermal growth factor receptors from different human carcinomas. (1987) (68)
- Human skin reconstruct models: a new application for studies of melanocyte and melanoma biology. (2001) (68)
- Isolation and chemical characterization of a melanoma-associated proteoglycan antigen. (1983) (68)
- Characterization of tenascin secreted by human melanoma cells. (1991) (68)
- Phenotypes and interactions of human melanocytes and keratinocytes in an epidermal reconstruction model. (1990) (67)
- Serum CEA and CA 19‐9: Potential future diagnostic or screening tests for gallbladder cancer? (1990) (67)
- Monoclonal anti-human tumor antibodies of six isotypes in cytotoxic reactions with human and murine effector cells. (1985) (64)
- Downregulation of CCN3 expression as a potential mechanism for melanoma progression (2008) (63)
- Lewis blood group antigens defined by monoclonal anti-colon carcinoma antibodies. (1984) (61)
- Development of invasive and growth factor-independent cell variants from primary human melanomas. (1991) (61)
- Characterization of Lewis antigens in normal colon and gastrointestinal adenocarcinomas. (1985) (60)
- Adhesion receptors in human melanoma progression. (1994) (59)
- Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes. (1987) (59)
- Use of monoclonal antibodies in detection of melanoma-associated antigens in intact human tumors. (1982) (59)
- Interactions of melanocytes and melanoma cells with the microenvironment. (1994) (58)
- Activated ras. Yet another player in melanoma? (1996) (57)
- Epidermal integrin expression is upregulated rapidly in human fetal wound repair. (1998) (57)
- Oncogenic BRAF regulates beta-Trcp expression and NF-kappaB activity in human melanoma cells. (2007) (56)
- Monoclonal antibody 425 inhibits growth stimulation of carcinoma cells by exogenous EGF and tumor‐derived EGF/TGF‐α (1990) (56)
- CO 17-1A and related monoclonal antibodies: their production and characterization. (1986) (55)
- Growth and phenotypic characteristics of human nevus cells in culture. (1988) (55)
- Monocyte chemoattractant protein‐1 (MCP‐1) inhibits the intestinal‐like differentiation of monocytes (2006) (54)
- Basic fibroblast growth factor in human melanoma. (1991) (54)
- AKT induces senescence in primary esophageal epithelial cells but is permissive for differentiation as revealed in organotypic culture (2007) (54)
- Expression of DR antigens in freshly frozen human tumors. (1982) (54)
- Nerve growth factor receptors in chromatin of melanoma cells, proliferating melanocytes, and colorectal carcinoma cells in vitro. (1988) (53)
- Protein kinases in normal and transformed melanocytes (1994) (52)
- Structural alteration in the MYB protooncogene and deletion within the gene encoding alpha-type protein kinase C in human melanoma cell lines. (1988) (52)
- Genetic and antigenic heterogeneity of different parapoxvirus strains. (1980) (52)
- A slow-cycling subpopulation of melanoma cells with highly invasive properties (2017) (52)
- Differential expression of protein kinase C and cAMP-dependent protein kinase in normal human melanocytes and malignant melanomas. (1990) (52)
- Stroma formation and angiogenesis by overexpression of growth factors, cytokines, and proteolytic enzymes in human skin grafted to SCID mice. (2003) (51)
- A t(1;19) chromosome translocation in three cases of human malignant melanoma. (1986) (50)
- Rapid apoptosis in the pulmonary vasculature distinguishes non-metastatic from metastatic melanoma cells. (2004) (49)
- Cisplatin down-regulation of cellular Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory proteins to restore tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human melanoma cells. (2003) (48)
- Nerve growth and expression of receptors for nerve growth factor in tumors of melanocyte origin. (1991) (48)
- Characterization of gastrointestinal tumor-associated carcinoembryonic antigen-related antigens defined by monoclonal antibodies. (1984) (48)
- All-trans retinoic acid (atRA) differentially induces apoptosis in matched primary and metastatic melanoma cells -- a speculation on damage effect of atRA via mitochondrial dysfunction and cell cycle redistribution. (2003) (47)
- The putative tumor suppressor BIN1 is a short-lived nuclear phosphoprotein, the localization of which is altered in malignant cells. (1997) (46)
- Periostin cooperates with mutant p53 to mediate invasion through the induction of STAT1 signaling in the esophageal tumor microenvironment (2013) (46)
- In Vitro Growth Patterns of Normal Human Melanocytes and Melanocytes from Different Stages of Melanoma Progression (1992) (45)
- Detection of carcinoembryonic antigen and related antigens in sera of patients with gastrointestinal tumors using monoclonal antibodies in double-determinant radioimmunoassays. (1983) (44)
- Protein tyrosine phosphatase genes downregulated in melanoma. (2001) (43)
- Carcinogenesis in human skin grafted to SCID mice. (1996) (43)
- Phenotypic characteristics of cells derived from precursors of human melanoma. (1983) (42)
- p53 alone or in combination with antisense cyclin D1 induces apoptosis and reduces tumor size in human melanoma (2002) (41)
- Development of pemphigus vulgaris-like lesions in severe combined immunodeficiency disease mice reconstituted with lymphocytes from patients. (1993) (41)
- Novel and known protein tyrosine kinases and their abnormal expression in human melanoma. (1993) (40)
- Mitogenic activity of laminin on human melanoma and melanocytes: different signal requirements and role of beta 1 integrins. (1995) (40)
- Multiparameter evaluation of the expression in situ of normal and tumor-associated antigens in human colorectal carcinoma. (1986) (38)
- Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells (2004) (38)
- Structure, function, and clinical significance of human tumor antigens. (1990) (38)
- Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma. (1987) (37)
- Naïve adult stem cells from patients with Hutchinson-Gilford progeria syndrome express low levels of progerin in vivo (2012) (37)
- Ex vivo perfusion of a tumor-containing colon with monoclonal antibody. (1981) (35)
- Quantitative dot blot analyses of blood‐group‐related antigens in paired normal and malignant human breast tissues (1992) (35)
- The expression of colorectal carcinoma-associated antigens in the normal colonic mucosa. An immunohistochemical analysis of regional distribution. (1989) (35)
- Immunoassay for melanoma-associated proteoglycan in the sera of patients using monoclonal and polyclonal antibodies. (1984) (35)
- Shedding of human tumor-associated antigens in vitro and in vivo. (1987) (35)
- Human Xenografts, Human Skin and Skin Reconstructs for Studies in Melanoma Development and Progression (2004) (34)
- Prolonged response to antisense cyclin D1 in a human squamous cancer xenograft model. (2000) (34)
- Tumor progression in the human melanocytic system. (1989) (34)
- Distinct patterns of DNA copy number alterations associate with BRAF mutations in melanomas and melanoma‐derived cell lines (2009) (33)
- No longer a molecular black box--new clues to apoptosis and drug resistance in melanoma. (2001) (33)
- Ex vivo perfusion of human colon with monoclonal anticolorectal cancer antibodies (1982) (33)
- Induction of p21 WAF1/CIP1 and Inhibition of Cdk2 Mediated by the Tumor Suppressor p16 INK4a (1999) (31)
- Growth regulation of cultured human nevus cells. (1993) (31)
- An antimelanoma monoclonal antibody and the histopathology of uveal melanomas. (1985) (30)
- Clinical protocol. Phase I trial to evaluate the safety of H5.020CMV.PDGF-b and limb compression bandage for the treatment of venous leg ulcer: trial A. (2004) (29)
- Flow cytometric determination of the frequency and heterogeneity of expression of human melanoma-associated antigens. (1989) (29)
- Selection of monoclonal antibodies detecting serodiagnostic human tumor markers. (1985) (28)
- Detection of a circulating gastrointestinal cancer antigen in sera of patients with gastrointestinal malignancies by a double determinant immunoassay with monoclonal antibodies against human blood group determinants. (1984) (28)
- Increased levels of circulating HLA-DR antigen in sera of patients with acute lymphoblastoid leukemia. (1984) (28)
- Microarray analysis of phosphatase gene expression in human melanoma (2005) (26)
- Hsu M, Andl T, Li G, Meinkoth JL, Herlyn MCadherin repertoire determines partner-specific gap junctional communication during melanoma progression. J Cell Sci 113: 1535-1542 (2000) (25)
- Human antibody induction to the idiotypic and anti-idiotypic determinants of a monoclonal antibody against a gastrointestinal carcinoma antigen. (1985) (25)
- Expression of colorectal carcinoma-associated antigens in colonic polyps. (1993) (24)
- UVB induction of epithelial tumors in human skin using a RAG-1 mouse xenograft model. (1997) (24)
- Production and Characterization of Monoclonal Antibodies to Peripheral and Central Nervous System Myelin (1984) (24)
- Interactions between growth factor receptors and corresponding monoclonal antibodies in human tumors (1987) (23)
- Expression and structure of human SPARC transcripts: SPARC mRNA is expressed by human cells involved in extracellular matrix production and some of these cells show an unusual expression pattern. (1990) (23)
- A simple procedure for determining Lewis phenotypes in human saliva. (1983) (22)
- Overexpression of IL-8 in the cornea induces ulcer formation in the SCID mouse (2006) (22)
- Raf inhibitor stabilizes receptor for the type I interferon but inhibits its anti-proliferative effects in human malignant melanoma cells (2007) (22)
- An antisense strategy for inhibition of human melanoma growth targets the growth factor pleiotrophin. (2000) (22)
- Tissue distribution and biochemical properties of an ocular melanoma-associated antigen. (1985) (21)
- Spontaneous and induced differentiation of human melanoma cells (1993) (21)
- Mechanisms of tumor growth inhibition. (1986) (20)
- Increased sensitivity in detecting tumor-associated antigens in sera of patients with colorectal carcinoma. (1984) (20)
- Pathophysiology of tumor progression in human gallbladder: flow cytometry, CEA, and CA 19-9 levels in bile and serum in different stages of gallbladder disease. (1989) (20)
- Human allogeneic melanoma‐reactive T‐helper lymphocyte clones: Functional analysis of lymphocyte‐melanoma interactions (1991) (18)
- A new organotypic model to study cell interactions in the intestinal mucosa (2006) (18)
- A versatile method for the removal of melanin from ribonucleic acids in melanocytic cells (2002) (18)
- Cytotoxicity of the matrix metalloproteinase–activated anthrax lethal toxin is dependent on gelatinase expression and B-RAF status in human melanoma cells (2008) (18)
- Lewis and related tumor-associated determinants on ovarian carcinoma. (1987) (18)
- Transformation of normal human melanocytes and non‐malignant nevus cells by adenovirus 12‐SV40 hybrid virus (1989) (18)
- Expression of integrin alpha10 is induced in malignant melanoma. (2006) (18)
- Comparative study of the binding characteristics of monoclonal antimelanoma antibodies. (1982) (18)
- Melanoma biology and progression. (2001) (17)
- Placental gene transfer: transgene screening in mice for trophic effects on the placenta. (2009) (17)
- A mucin containing the X, Y, and H type 2 carbohydrate determinants is shed by carcinoma cells. (1987) (16)
- Cultivation of normal human epidermal melanocytes. (1996) (15)
- Cytokine modulation of antigen expression in human melanoma cell lines derived from primary and metastatic tumour tissues (1997) (15)
- Regulation of growth and phenotype of normal human melanocytes in culture. (1991) (15)
- Cyclin D 1 Is a Candidate Oncogene in Cutaneous Melanoma 1 (2002) (15)
- Immunophenotyping of compound and spitz nevi and vertical growth-phase melanomas using a panel of monoclonal antibodies reactive in paraffin sections. (1993) (15)
- Cellular pathways leading to melanoma differentiation: therapeutic implications (1994) (15)
- The Nerve Growth Factor Receptor in Normal and Transformed Neural Crest Cells a (1986) (14)
- Circulating tumor markers and assessment or response to intrahepatic chemotherapy of colon carcinoma (1985) (14)
- The administration schedule of cyclin-dependent kinase inhibitor gene therapy and etoposide chemotherapy is a major determinant of cytotoxicity. (1999) (14)
- Nesbit M, Nesbit HK, Bennett J, Andl T, Hsu MY, Dejesus E, McBrian M, Gupta AR, Eck SL, Herlyn MBasic fibroblast growth factor induces a transformed phenotype in normal human melanocytes. Oncogene 18: 6469-6476 (1999) (14)
- Common antigenic sites on exfoliated cells derived from cervical carcinoma and in tumor cells of nonuterine origin as demonstrated by monoclonal antibodies in immunoperoxidase assay. (1985) (14)
- Radioimmunodetection of human tumor xenografts by monoclonal antibody F(ab')2 fragments. (1986) (14)
- Thrombospondin Receptor (CD36) Expression of Human Keratinocytes during Wound Healing in a SCID Mouse/Human Skin Repair Model (1996) (13)
- Growth‐factor‐independence and invasive properties of colorectal carcinoma cells (1992) (13)
- Repopulation of Langerhans cells during wound healing in an experimental human skin/SCID mouse model. (1996) (13)
- [Stability in drinking and surface water of nine virus species from different genera (author's transl)]. (1977) (13)
- Tumor progression in melanoma: the biology of epidermal melanocytes in vitro. (1989) (13)
- Expression of Integrin Alpha10 Is Induced in Malignant Melanoma (2007) (13)
- Development of monoclonal antibodies that recognize antigens associated with human cervical carcinoma. (1986) (12)
- Suppression of BRAFV 599 E in Human Melanoma Abrogates Transformation 1 (2003) (12)
- Metastatic uveal melanoma: an ocular melanoma associated antigen in the serum of patients with metastatic disease. (1986) (11)
- Experimental model of human melanoma metastases. (1991) (11)
- Studies of mammalian ornithine decarboxylase using a monoclonal antibody. (1984) (10)
- Identification and isolation of Lewis blood group antigens from human saliva using monoclonal antibodies. (1984) (10)
- [Control of ecthyma contagiosum (pustular dermatitis) of sheep with a new parenteral cell culture live vaccine]. (1981) (10)
- Epitope- and antigen-specific cancer vaccines. (1991) (9)
- Ultraviolet B–induced squamous epithelial and melanocytic cell changes in a xenograft model of cancer development in human skin (1998) (9)
- Adenovirus infection enhances killing of melanoma cells by a mitotoxin. (1997) (9)
- Human milk fat globule membrane glycoproteins express blood group-related determinants primarily on mucin-like epithelial membrane antigens and gp70. (1990) (8)
- Antigens in ocular and cutaneous melanomas. (1983) (8)
- Adenovirus-Mediated Ex Vivo Gene Transfer of Human Vascular Endothelial Growth Factor in a Rabbit Laryngotracheal Reconstruction Model (2002) (8)
- α5 and α2 Integrin Gene Transfers Mimic the PDGF-B–Induced Transformed Phenotype of Fibroblasts in Human Skin (2001) (8)
- Expression of PKC isoforms in human melanocytic cells in situ. (2006) (7)
- Transforming growth factor-alpha secretion by epidermal growth factor-dependent human tumor cell lines. (1990) (7)
- Experimental induction of human atypical melanocytic lesions and melanoma in ultraviolet-irradiated human skin grafted to immunodeficient mice. (2001) (6)
- Differential diagnosis between mesotheliomas and metastatic adenocarcinomas using monoclonal antibodies against gastrointestinal carcinoma antigen and stage-specific embryonic antigen. (1986) (5)
- Monoclonal antibodies to melanoma-associated antigens, hybridomas that produce these antibodies, and their use. (1988) (5)
- Characteristics of cultured human melanocytes from different stages of tumor progression. (1988) (5)
- Irish society of gastroenterology (1992) (5)
- Placental Gene Transfer: Transgene Screening in Mice for Trophic Effects on the Placenta (2011) (5)
- Stable Transfection of Human Malignant Melanoma Cells with Basic Fibroblast Growth Factor Antisense cDNA a (1992) (5)
- Vascular Endothelial Growth Factor Is a Marker of Tumor Invasion and Metastasis in Squamous Cell Carcinomas of the Head and Neck 1 (1999) (4)
- The prevalence of interferon-alpha transcription defects in malignant melanoma (2005) (4)
- Alpha5 and alpha2 integrin gene transfers mimic the PDGF-B-induced transformed phenotype of fibroblasts in human skin. (2001) (4)
- Antigens associated with tumor progression in melanocytic neoplasia. (2008) (4)
- Rapid dissociation of adherent human tumor cells by ultrasound. (1987) (4)
- Advances in Brief Constitutive Mitogen-activated Protein Kinase Activation in Melanoma Is Mediated by Both BRAF Mutations and Autocrine Growth Factor Stimulation 1 (2003) (4)
- [Comparative studies on the demonstration and formation of serum antibodies against the Borna virus]. (1978) (4)
- Detection of murine immunoglobulin in human tissues following therapeutic infusion of monoclonal antibody. (1986) (4)
- CD20-immunotargeting of malignant melanoma. (2010) (3)
- Effector Cells in ADCC with Anti-Breast Cancer Monoclonal Antibodies (1985) (3)
- Immunodiagnosis of Human Solid Tumours (1984) (3)
- The human melanocyte system as a model for studies on tumor progression. (1991) (3)
- Cellular immunity and the immunotherapy of cancer (2007) (2)
- [Growth factors in the pathogenesis of malignant diseases]. (2008) (2)
- Association of polymorphisms of FAS-1377, FAS-670, and FASL-844 genes with risk factors for cutaneous malignant melanoma. (2007) (2)
- Generation of natural killer-like activity in mixed lymphocyte-tumor cell cultures. I. Role of HLA-DR antigens as stimulatory molecules. (1985) (2)
- Biology of melanocytes and melanoma in human skin reconstructs (2000) (2)
- [Peroral immunization against pox. 5. Effectiveness of drinking water vaccination against fowl pox]. (2010) (2)
- In vitro skin reconstructs to study cell-cell and cell-matrix interactions in human melanoma (1998) (2)
- Human breast cancer associated fibroblasts exhibit subtype specific gene expression profiles (2012) (1)
- Stimulation of phagocytic activity by dextran. (1972) (1)
- Abstract 1239: CDKN2B loss promotes progression from benign melanocytic nevus to melanoma (2015) (1)
- Evaluation of monoclonal antibody to 19-9 antigen as a potential screening technique for colorectal cancer in a high-risk population. (1984) (1)
- Human tumor antigens (1985) (1)
- Isolation and analysis of novel human melanocyte-specific cDNA clones. (1994) (0)
- Ovarian Surface Epithelium The Differential Role of L 1 in Ovarian Carcinoma and Normal (2008) (0)
- Growth factors with autocrine and paracrine functions in melanoma progression and invasion: 72 (1993) (0)
- Insulin-like Growth Factor-1 Induces Survival and Growth of Biologically Early Melanoma Cells through Both the Mitogen-activated Protein Kinase and (cid:1) -Catenin Pathways 1 (2001) (0)
- Advances in Brief Induction of Melanoma Phenotypes in Human Skin by Growth Factors and Ultraviolet (2004) (0)
- Metastatic but not primary melanoma cells escape from neutrophil attack induced by adenoviral gene transfer of interleukin-8 (1998) (0)
- T Cell Receptor (TCR) Structure of Autologous Melanoma-reactive Cytotoxic T Lymphocyte (CTL) Clones: Tumor-lnfiltrating Lymphocytes Overexpress In Vivo the TCR f3 Chain Sequence Used by an HLA-A2-restricted and Melanocyte-lineage-specific (2003) (0)
- Dynamics of Cell Adhesion Interactions during Melanoma Development (2005) (0)
- The Basement Membrane in Benign and Malignant Melanocytic Lesions1 (1992) (0)
- Mechanisms of hepatocyte growth factor induced regulation of cell adhesion in melanocytic cells (2007) (0)
- 044 Adenoviral Gene Transfer of IL‐10 Differentially Regulates Hyaluronic Acid Synthase 1: Implications for Scarless Wound Healing (2004) (0)
- Patents and literature (1985) (0)
- Melanoma: Mutations in Multiple Pathways at the Tumor-Stroma Interface (2010) (0)
- Irish Society of Gastroenterology (1993) (0)
- [Stability of Teschen, HCC, ND and vaccinia viruses against 5 disinfectants]. (1976) (0)
- Identificationof Melanoma-associatedAntigensUsingFixedTissue Screeningof Antibodies1 (2006) (0)
- Monoclonal antibodies and immobilized antibodies (1987) (0)
- Gene expression of RNA for b3 integrin and CD9 in malignant melanoma and melanocytic nevi, evaluated by cDNA expression array profiling (1999) (0)
- Fifteenth Sir Peter Freyer Memorial Lecture and Surgical Symposium Proceedings of meeting held 14th & 15th September, 1990 at University College, Galway (1991) (0)
- Irish association for cancer research (1991) (0)
- Nerve Growth Factor Receptors in Chromatin of Melanoma Cells , Proliferating Melanocytes , and Colorectal Carcinoma Cells in Vitro 1 (2006) (0)
- Monoclonal antibodies allow differentiation between carcinoma dysplasia hyperplasia and cholecystitis in human gallbladder sections (1986) (0)
- Differences in antigen expression between neoplastic and nonneoplastic gallbladder epithelium (2005) (0)
- A 19-9 monoclonal antibody study of adenocarcinoma metastatic to the choroid. (1984) (0)
- Dynamicsof Celli Nteractions Andc Ommunications Duringmelanomadevelopment (0)
- Sixteenth sir peter freyer memorial lecture and surgical symposium September 13th & 14th, 1991 Session I (1992) (0)
- Recognition of lineage-specific antigens on melanoma and melanocytes by HLA-A2-restricted cytolytic T cell clones: 75 (1993) (0)
- Monoclonal antibodies against antigens associated with melanoma, hybrid cell lines producing these antibodies, and their corresponding employment. (1988) (0)
- 153 Utility of adenoviruses as gene expression vectors in melanocytic cells (1997) (0)
- Royal Academy of Medicine in Ireland Section of Sugery (1989) (0)
- [Interview with Dr. M. Herlyn, Philadelphia. The new magic formula: monoclonal antibodies]. (1983) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Meenhard Herlyn?
Meenhard Herlyn is affiliated with the following schools: